Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety Evaluation of AdimFlu-S Quadrivalent Inactivated Influenza Vaccine (QIS) in Healthy Subjects Aged 3 Years Old to 17 Years Old

NCT04101435 is registered in ClinicalTrials.gov with Adimmune Corporation as lead sponsor.

NCT NCT04101435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04101435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety Evaluation of AdimFlu-S Quadrivalent Inactivated Influenza Vaccine (QIS) in Healthy Subjects Aged 3 Years Old to 17 Years Old
Lead sponsor
Adimmune Corporation
Phase
Phase 3
Overall status
Completed
Start date
December 28, 2016
Completion date
December 27, 2017
Enrollment
174 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

influenza